Current stock page

Financial Data

BHC Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareDrug Manufacturers - Specialty & GenericScore data as of Oct 30, 2026

BHCBausch Health Companies Inc.

Healthcare / Drug Manufacturers - Specialty & Generic

Leader

Sector Leader

BullishEdge 10/10
$8.20−$0.71 (−7.97%)

Latest quote

  • Momentum
    79
  • Value
    75
  • Quality
    100
  • Risk resilience
    24
  • Sentiment
    57
algovestiq.comScore data as of Oct 30, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
4
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Oct 31, 2026.

Income statement
4 periods
Metric2026-06-302026-03-312025-12-312025-09-30
Revenue$2.85B$2.52B$2.8B$2.68B
Gross Profit$2.08B$1.79B$2B$1.93B
Operating Income$775M$521M$829M$636M
Net Income$258M-$1.42B-$112M$179M
EPS$0.67-$3.79-$0.31$0.48
Cash flow statement
4 periods
Metric2026-06-302026-03-312025-12-312025-09-30
Operating Cash Flow$670M$230M$495.92M$405M
Capital Expenditure-$77M-$147M-$93.39M-$91M
Free Cash Flow$593M$83M$402.53M$314M
Net Cash Provided By Operating Activities$670M$230M$495.92M$405M
Balance sheet
3 periods
Metric2026-06-302026-03-312025-12-31
Total Assets$24.79B$24.5B$26.37B
Total Debt$9.41B$10.93B-$14.46B
Cash And Cash Equivalents———
Total Liabilities$25.6B$25.58B$25.99B
Total Stockholders Equity-$802M-$1.08B$377M
Key financial metrics
3 periods
Metric2026-06-302026-03-312025-12-31
P/E ratio1.84-0.36-5.6
P/B ratio-1.04-0.98-4.66
P/S ratio0.650.80.92
Debt To Equity-11.73-10.1-38.35
Free Cash Flow Yield32.08%4.12%15.63%
Financial ratios
4 periods
Metric2026-06-302026-03-312025-12-312025-09-30
P/E ratio1.84-0.36-5.63.36
P/B ratio-1.04-0.98-4.66-4.24
P/S ratio0.650.80.920.89
Return On Equity-14.57%69.11%20.25%-31.71%
Debt To Equity-11.73-10.1-38.35-37.24

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe-2.19x
Pb-1.37x
Gross Margin71.82%
Operating Margin25.44%
ROE88.77%
ROIC13.07%
Debt To Equity-11.73
FCF Yield57.55%

As of Oct 29, 2026

Technical indicators
MetricValue
Close
As of Oct 30, 2026
$8.20
Volume
As of Oct 29, 2026
32.97M
RSI (14)
As of Oct 29, 2026
78.53
MACD
As of Oct 29, 2026
0.35
MACD signal
As of Oct 29, 2026
0.15
MACD histogram
As of Oct 29, 2026
0.2
ADX (14)
As of Oct 29, 2026
22.8
SMA (50)
As of Oct 29, 2026
$6.21
SMA (200)
As of Oct 29, 2026
$5.70
ATR (14)
As of Oct 29, 2026
$0.41
Historical volatility (annualized)
As of Oct 29, 2026
108.07%
Volume (20-day average)
As of Oct 29, 2026
3.83M
Risk measures
MetricValue
Resilience score24/100
Beta0.37
Annual volatility63.62%
Max Drawdown-43.92%
Sharpe Ratio0.88
VaR (95%, 1-day)-4.42%

As of Oct 29, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

BHC Financial Data FAQ

What is Bausch Health Companies Inc.'s revenue?

Bausch Health Companies Inc.'s revenue is one of the core financial data points for BHC. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Bausch Health Companies Inc.'s revenue growing?

Revenue growth shows whether Bausch Health Companies Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is BHC's EPS?

BHC's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Bausch Health Companies Inc.'s net income?

Bausch Health Companies Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Bausch Health Companies Inc. generate?

Free cash flow shows how much cash Bausch Health Companies Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Bausch Health Companies Inc. have?

Cash and debt help frame BHC's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.